Before agreeing to invest $200 million in India's Gland Pharma, KKR looked at a couple of opportunities in the injectable drugs space in the US and another in India over a period of several...
Expansion | 04 Dec 2013 |
Accel Partners and Ventureast have contributed INR480 million ($7.69 million) in Series A funding for Indian home healthcare provider Portea Medical.
South Asia | 03 Dec 2013 |
A consortium of investors including Archer Capital has scrapped its bid for New Zealand's Abano Healthcare Group. The group, which also featured Healthcare Industry Limited (HIL) and Steamboat Capital, cited a downgrade in the company's forecast profit...
Australasia | 29 Nov 2013 |
Jintian Pharmaceutical Group, a Chinese pharmaceutical retailer and distributor backed by CVC Capital Partners and SEAVI Advent Private Equity, is seeking to raise as much as $273 million through an IPO in Hong Kong.
Greater China | 28 Nov 2013 |
KKR has agreed to buy a minority stake in Gland Pharma, an Indian injectable drugs manufacturer, for approximately $200 million. The investment facilitates the exit of 3Logi Capital’s Evolvence India Life Sciences Fund.
South Asia | 28 Nov 2013 |
PE-backed China Cinda Asset Management Corp, one of four groups set up to absorb non-performing loans (NPLs) from the country’s Big Four state-owned banks, is expected to raise up to $2.5 billion in its Hong Kong IPO.
Exits | 22 Nov 2013 |
Temasek Holdings and Shanghai-based Greenwoods Investment have made a pre-IPO investment in Phoenix Healthcare Group, picking up a 10% stake in the company for RMB165 million ($26.8 million).
Greater China | 19 Nov 2013 |
Advent International has appointed healthcare industry veteran Lincoln Chee to its operating partner program in China. He will advise the private equity firm in identifying investment opportunities in the space and in generating value in portfolio companies....
Greater China | 13 Nov 2013 |
China New Enterprise Investment (CNEI) has acquired a 17% stake in Fudan-Zhangjiang Bio-Pharmaceutical (FDZJ) for $25.4 million, becoming the second-largest shareholder in the Shanghai based bio-pharmaceutical firm.
Greater China | 05 Nov 2013 |
Darby Private Equity, the PE arm of Franklin Templeton Investments, has exited its investment in Symbiotec Pharmalab to Actis. Financial terms were not disclosed.
South Asia | 04 Nov 2013 |
Sequoia Capital has led INR1 billion ($16.3 million) investment into Bangalore-based infant and maternity care hospital chain Cloudnine. Existing investor Matrix Partners also participated in the round.
South Asia | 31 Oct 2013 |
KKR has made an INR5.5 billion ($89.74 million) investment in PCR Investments, the holding company of India’s Apollo Hospitals group.
Healthcare | 29 Oct 2013 |
Qiming Venture Partners has committed a Series A round of funding to Jun He Tang, a traditional Chinese medicine business. Financial terms were not disclosed.
Greater China | 28 Oct 2013 |
Tata Capital’s offshore Tata Opportunities Fund (TOF) has acquired a 5% stake in direct-to-home (DTH) TV provider Tata Sky, while VC fund Tata Capital Innovations has backed cancer care company Mitra Biotech.
South Asia | 24 Oct 2013 |
Updating your subscription status
India's private equity industry is in a state of transition, and only funds that are nimble on their feet and adaptive will ultimately survive. Find out what you need to navigate India's changing landscape at the 14th Annual AVCJ Private Equity & Venture India Forum on 5-6 December. Last year's Forum was attended by more than 250 top executives coming from 15 different countries and territories around the globe. Over 50 LPs joined the event, including dozens of foreign investors looking to increase their allocations to India or to invest in the country for the very first time. The conference featured in-depth analysis about India's private equity industry with sessions that covered topics ranging from confronting the difficult exit and fundraising environment, to understanding regulatory changes, to predicting where the industry will likely be in 2015.
Date: 5-6 December 2013
Venue: Tal Lands End, Mumbai
Join us at the 11th Annual AVCJ Private Equity & Venture Australia and New Zealand Forum on 5-7 March at the Four Seasons Hotel in Sydney to find out how funds of varying size are raising capital, sourcing deals and exits, as well as all you need to know to effectively navigate Australasia's changing alternative asset landscape.
After a decade-long mining boom the economy is experiencing a loss of momentum and the resulting deal flow reduction and lack of value in the market means GPs are chasing many of the same acquisition targets. That said, the exit market is recovering with both IPOs and M&A activity picking up, and an increase in LPs appetite for the asset class, and the recent government change means that the industry is cautiously optimistic for the future and expecting a rise in activity over the next 12 months.
, Four Seasons Hotel, Sydney